Search Results - "NAGATOSHI, Y"

CD34+CD38+CD19+ as well as CD34+CD38−CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL by Kong, Y, Yoshida, S, Saito, Y, Doi, T, Nagatoshi, Y, Fukata, M, Saito, N, Yang, S M, Iwamoto, C, Okamura, J, Liu, K Y, Huang, X J, Lu, D P, Shultz, L D, Harada, M, Ishikawa, F

“…The presence of rare malignant stem cells supplying a hierarchy of malignant cells has recently been reported. In human acute myelogenous leukemia (AML), the…”
Get full text

Hypercalcemia in childhood acute lymphoblastic leukemia : frequent implication of parathyroid hormone-related peptide and E2A-HLF from translocation 17;19 by INUKAI, T, HIROSE, K, GOTO, H, ENDO, M, MORIMOTO, A, IMAIZUMI, M, KAWAMURA, N, MIYAJIMA, Y, OHTAKE, M, MIYAJI, R, SAITO, M, TAWA, A, INABA, T, YANAI, F, GOI, K, NAKAZAWA, S, SUGITA, K, KUROSAWA, H, HAMA, A, INADA, H, CHIN, M, NAGATOSHI, Y, OHTSUKA, Y, ODA, M

“…Hypercalcemia is relatively rare but clinically important complication in childhood leukemic patients. To clarify the clinical characteristics, mechanisms of…”
Get full text

Improved outcome of refractory Langerhans cell histiocytosis in children with hematopoietic stem cell transplantation in Japan by Kudo, K, Ohga, S, Morimoto, A, Ishida, Y, Suzuki, N, Hasegawa, D, Nagatoshi, Y, Kato, S, Ishii, E

“…Langerhans cell histiocytosis (LCH) that is refractory to conventional chemotherapy has a poor outcome. Hematopoietic stem cell transplanta tion (SCT) is a…”
Get full text

Cidofovir for treating adenoviral hemorrhagic cystitis in hematopoietic stem cell transplant recipients by NAGAFUJI, K, AOKI, K, HARADA, M, HENZAN, H, KATO, K, MIYAMOTO, T, ETO, T, NAGATOSHI, Y, OHBA, T, OBAMA, K, GONDO, H

“…Adenovirus (AdV) infection is an important cause of morbidity and mortality in hematopoietic stem cell transplant (HSCT) recipients. We treated 16 patients…”
Get full text

Low-dose MTX for the treatment of acute and chronic graft-versus-host disease in children by Inagaki, J, Nagatoshi, Y, Hatano, M, Isomura, N, Sakiyama, M, Okamura, J

“…We report the results of a retrospective analysis in 27 pediatric patients who received low-dose MTX as the second-line treatment for steroid-refractory or…”
Get full text

TBI and melphalan followed by allogeneic hematopoietic SCT in children with advanced hematological malignancies by Inagaki, J, Nagatoshi, Y, Sakiyama, M, Nomura, Y, Teranishi, H, Sasaki, T, Okamura, J

“…We evaluated the efficacy and safety of the conditioning regimen that consisted of TBI and melphalan (L-PAM), followed by hematopoietic SCT (HSCT) in 23…”
Get full text

Disease stage stratified effects of cell dose in unrelated BMT for hematological malignancies: a report from Japan marrow donor program by Inamoto, Y, Miyamura, K, Okamoto, S, Akiyama, H, Iida, H, Eto, T, Morishima, Y, Kawa, K, Kikuchi, A, Nagatoshi, Y, Tanaka, J, Ashida, T, Hirokawa, M, Tsuchida, M, Mori, S

“…Cell dose is one of the major factors that can be manipulated in unrelated BMT. However, regarding disease-stage-stratified effects of cell dose, data are…”
Get full text

Polymorphisms of transforming growth factor-β1 and transforming growth factor-β1 type II receptor genes are associated with acute graft-versus-host disease in children with HLA-matched sibling bone marrow transplantation by HATTORI, H, MATSUZAKI, A, SUMINOE, A, IHARA, K, NAGATOSHI, Y, SAKATA, N, KAWA, K, OKAMURA, J, HARA, T

“…The aim of this study was to determine whether the gene polymorphisms of Th1/Th2 and immunoregulatory cytokines were associated with aGVHD in Japanese children…”
Get full text

Unrelated bone marrow transplantation using a reduced-intensity conditioning regimen for the treatment of Kostmann syndrome by Fukano, R, Nagatoshi, Y, Shinkoda, Y, Saito, Y, Takahashi, D, Hatanaka, M, Nagayama, J, Ayukawa, H, Okamura, J

Get full text

Pharmacokinetic and pharmacodynamic investigation of irinotecan hydrochloride in pediatric patients with recurrent or progressive solid tumors by Kimura, T, Kashiwase, S, Makimoto, A, Kumagai, M, Taga, T, Ishida, Y, Ida, K, Nagatoshi, Y, Mugishima, H, Kaneko, M, Barrett, J S

“…A multicenter Phase I/II study of Irinotecan hydrochloride (CPT-11; 40-45 mg/m(2)/dose) was conducted for the treatment of refractory pediatric solid tumors…”
Get full text

Busulfex (i.v. BU) and CY regimen before SCT: Japanese-targeted phase II pharmacokinetics combined study by Kim, S-W, Mori, S-i, Tanosaki, R, Fukuda, T, Kami, M, Sakamaki, H, Yamashita, T, Kodera, Y, Terakura, S, Taniguchi, S, Miyakoshi, S, Usui, N, Yano, S, Kawano, Y, Nagatoshi, Y, Harada, M, Morishima, Y, Okamoto, S, Saito, A M, Ohashi, Y, Ueda, R, Takaue, Y

“…To evaluate the toxicity and efficacy of an i.v. preparation of BU (12.8 mg/kg), combined with CY (120 mg/kg), a prospective study was performed on 30 Japanese…”
Get full text

Methotrexate vs Cyclosporin A as a single agent for graft-versus-host disease prophylaxis in pediatric patients with hematological malignancies undergoing allogeneic bone marrow transplantation from HLA-identical siblings: a single-center analysis in Japan by KOGA, Y, NAGATOSHI, Y, KAWANO, Y, OKAMURA, J

“…The efficacy of methotrexate (MTX) as a single graft-versus-host disease (GVHD) prophylaxis agent was compared to that of cyclosporin A (CSA) in 62 pediatric…”
Get full text

Unrelated bone marrow transplantation using a reduced intensity-conditioning regimen in leukocyte adhesion deficiency by Takahashi, D, Nagatoshi, Y, Saito, Y, Inagaki, J, Nagayama, J, Shinkoda, Y, Fujita, K, Okamura, J

Get full text

Therapy-related myelodysplastic syndrome in childhood: A retrospective study of 36 patients in Japan by Tsurusawa, M., Manabe, A., Hayashi, Y., Akiyama, Y., Kigasawa, H., Inada, H., Noguchi, Y., Sawai, N., Kobayashi, R., Nagatoshi, Y., Kawakami, K., Kojima, S., Nakahata, T.

“…We report here a retrospective analysis of 36 children with therapy-related myelodysplastic syndrome (t-MDS) diagnosed between 1990 and 1999 in Japan. Their…”
Get full text

Thymus-independent expansion of T lymphocytes in children after allogeneic bone marrow transplantation by HONDA, K, TAKADA, H, NAGATOSHI, Y, AKAZAWA, K, OHGA, S, ISHII, E, OKAMURA, J, HARA, T

“…The contribution of the thymus-dependent pathway and thymus-independent pathways for T cell regeneration after BMT in children is still unclear. We analyzed…”
Get full text

Bilateral basal ganglial necrosis after allogeneic bone marrow transplantation in a child with Kostmann syndrome by SUGA, N, NAGATOSHI, Y, GONDOU, K, KIRA, R, IKUNO, Y, OKAMURA, J

“…A 6-year-old girl underwent allogeneic BMT from a matched sibling donor for the treatment of Kostmann syndrome. She suddenly became drowsy on day 30 after BMT,…”
Get full text

An investigator-initiated registration-directed phase I/II clinical trial of irinotecan hydrochroride for refractory pediatric solid tumors by Makimoto, A., Mugishima, H., Taga, T., Ishida, Y., Nagatoshi, Y., Ida, K., Kumagai, M., Kimura, T., Ohashi, Y., Kaneko, M.

“…Abstract only…”
Get full text

Primary Ewing's Sarcoma Family Tumors of the Lung - a Case Report and Review of the Literature by Takahashi, Daijiro, Nagayama, Jun, Nagatoshi, Yoshihisa, Inagaki, Jiro, Nishiyama, Kenichi, Yokoyama, Ryohei, Moriyasu, Yosio, Okada, Kenji, Okamura, Jun

“…Ewing's sarcoma family tumors (ESFT) have been reported to originate in a variety of sites, most commonly in the extremities. We herein report a case of a…”
Get full text

Acute lymphocytic leukemia in adolescence with multiple osteolytic lesions and hypercalcemia mediated by lymphoblast-producing parathyroid hormone-related peptide: A case report and review of the literature by Shimonodan, Hidemi, Nagayama, Jun, Nagatoshi, Yoshihisa, Hatanaka, Michiki, Takada, Akiko, Iguchi, Haruo, Oda, Yoshinao, Okamura, Jun

“…Background Osteopathy is one of the common initial symptoms of acute lymphocytic leukemia (ALL) in children and adolescents, but multiple osteolysis…”
Get full text

Sensorless vector control of induction motor at zero frequency by Takeshita, T., Nagatoshi, Y., Matsui, N.

“…This paper presents a sensorless vector control scheme for low speed drive. The sensorless algorithm is based on the estimation of the secondary speed EMF that…”
Get full text